Cardio-TriTest vs VX1+
AI Verdict
Choose Cardio-TriTest if…
Choose Cardio-TriTest if your primary care clinic requires a comprehensive, non-invasive diagnostic tool for early and broad cardiovascular disease detection. This device is ideal for synchronizing and visually correlating multiple heart bio-signals (ECG, PCG, MCG) to provide a more complete initial assessment of cardiac health.
View Cardio-TriTest →Choose VX1+ if…
Choose VX1+ if your electrophysiology lab needs real-time AI-powered assistance during cardiac ablation procedures for atrial fibrillation and tachycardia. This software is specifically designed to help electrophysiologists identify abnormal electrograms and provide AI-driven insights to optimize ablation strategies within existing EP recording and 3D mapping systems.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardio-TriTest | VX1+ |
|---|---|---|
| Deployment | On-premise (device) | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| FDA Status | Unknown | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardio-TriTestCardio-TriTest is designed for primary care, offering a non-invasive test that integrates into existing ECG workflows and can be operated by nurses or healthcare assistants. Its visual correlation of bio-signals simplifies interpretation for general practitioners, making it accessible to a broader clinical audience.
Clinical Value
VX1+VX1+ offers real-time AI assistance during complex cardiac ablation procedures, with a randomized controlled trial (TAILORED-AF) demonstrating superior clinical outcomes and increased freedom from atrial fibrillation. While Cardio-TriTest provides valuable early detection in primary care, VX1+'s proven impact on the efficacy of a high-stakes interventional procedure gives it a stronger, more direct clinical impact.
Pricing & Value
Cardio-TriTestBoth tools lack public pricing transparency. However, Cardio-TriTest's related product, Cardio-HART, indicates a hybrid pricing model (device purchase + annual software subscription) and mentions reimbursement in several regions, offering more insight into its value proposition and potential for financial viability.
Enterprise Readiness
Cardio-TriTestCardio-TriTest explicitly states it is HIPAA compliant and ISO 13485-certified, and its related product supports EHR integration via standard HL7 and FHIR protocols. While VX1+ is FDA cleared and states compliance with applicable laws, its HIPAA compliance is noted as 'expected' in the structured facts, and its privacy policy defers HIPAA PHI handling to healthcare providers' notices, indicating less explicit enterprise-level compliance details. [cite: 19, JSON]
Innovation
TieCardio-TriTest is innovative with its AI-powered 3-in-1 diagnostic device combining ECG, PCG, and MCG for comprehensive early cardiovascular disease detection in primary care. [cite: 26, JSON] VX1+ is equally innovative as the first FDA-cleared AI tool providing real-time, in-procedure guidance for complex cardiac ablation, directly impacting surgical outcomes. [cite: 1, JSON] Both represent significant advancements in their respective cardiology sub-domains.
Support & Docs
VX1+Volta Medical, the company behind VX1+, provides readily accessible 'Instructions For Use (IFU)' and 'User Manuals' for its products on its website. In contrast, Cardio-Phoenix Inc. has limited publicly available information regarding customer support infrastructure or detailed documentation for its related product, Cardio-HART, beyond a general contact email, although it mentions clinical support with a subscription.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardio-TriTest | VX1+ |
|---|---|---|
| Name | Cardio-TriTest | VX1+ |
| Company | Cardio-Phoenix Inc. | Volta Medical |
| Primary Use Case | AI-powered 3-in-1 diagnostic device for earlier and more comprehensive cardiovascular disease detection in primary care. | AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Primary Diagnostic/Procedural Focus | Cardiovascular disease detection | Real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Key Diagnostic Modalities/Input Data | 3-in-1 diagnostic device (ECG, PCG, MCG); 12-Lead Electrocardiograph (ECG); 4 Lead Phonocardiograph (PCG); 4 Lead Mechanocardiograph (MCG). | Identification of spatio-temporal dispersed electrograms (DEs); Input from existing EP recording and 3D mapping systems. |
| AI-Powered Analysis Focus | AI-powered analysis for heart disease detection; Synchronized bio-signal acquisition and visual correlation of heart bio-signals. | AI-driven insights to assist electrophysiologists during ablation procedures; Real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart. |
| Compatibility/Integration | Not specified | Compatibility with existing 510(k)-cleared catheters and specific data acquisition systems (e.g., Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, Abbott EnSite X 3D mapping system). |
Videos
Demos, reviews, and walkthroughs featuring Cardio-TriTest and VX1+.